Commence announced on July 22, 2025, the launch of Amplify, a next-generation, AI-powered platform designed to revolutionize medical record intake, clinical review, and case workflows for healthcare and government programs in Washington, D.C., and beyond. Comprising three integrated modules—Capture, Review, and Clarity—Amplify automates data retrieval, enhances interoperability, and delivers actionable insights, addressing inefficiencies in the $120 billion healthcare IT market. By leveraging advanced NLP, handwriting recognition, and FHIR-compliant APIs, it reduces administrative burden by up to 70% and ensures compliance with federal security standards.
Announced July 22, 2025: Amplify platform launched by Commence for healthcare data workflows.
Modules: Capture (data intake), Review (AI-augmented analysis), Clarity (case management).
Reduces administrative workload by 70% and review times by 50%, per Commence data.
Supports FHIR, JSON, and EHR integrations for seamless interoperability.
Targets $120B healthcare IT market, projected to reach $220B by 2030.
Ensures HIPAA-compliant security for PHI, PII, and CUI data.
Amplify addresses fragmented health data workflows by focusing on unstructured medical content from the outset. “We built Amplify to solve the problem before the workflow,” said Ian Checcio, Chief Growth Officer at Commence. “It’s not about bolting on AI to a broken process—it’s about starting with the data itself.” The platform’s modules include:
Capture: Unifies intake from email, fax, HIEs, and mail, processing PDFs, images, and CSVs, standardizing data to reduce provider burden by 60%.
Review: Uses NLP and handwriting recognition to automate summarization, tagging, and evidence linking, cutting clinical review times by 50%.
Clarity: Orchestrates dynamic case management for audits, appeals, and benefit determinations, improving throughput and transparency.
Key features include noise reduction (removing duplicates), natural language search, and standards-based interoperability with EHRs and claims systems, ensuring compliance with HIPAA and federal standards.
Commence, a Washington, D.C.-based healthcare IT innovator, targets government and commercial healthcare programs facing rising costs and fraud. Amplify competes with platforms like Ambience Healthcare and AmplifyMD, but its modular, data-first approach and focus on unstructured data set it apart. The platform aligns with the $120 billion healthcare IT market’s growth, driven by 68% of providers citing administrative burden as a key challenge, per 2025 reports. Client data shows Amplify reduces review times by 50% and fraud detection errors by 30%.
The healthcare IT sector struggles with data silos, with 81% of organizations facing interoperability issues, per 2025 industry reports. Amplify’s integration with FHIR and JSON addresses this, similar to Amplify Care’s clinician-led solutions for streamlined workflows. Posts on X from @HealthTechWire praise Amplify’s launch for its potential to transform clinical reviews. The platform’s AI-driven approach aligns with trends like Ambience Healthcare’s 27% coding accuracy improvement, emphasizing compliance and efficiency. Commence’s focus on end-to-end security positions it to meet rising demand for HIPAA-compliant solutions.
Commence’s Amplify platform redefines healthcare data management, leveraging AI to streamline medical record intake, clinical reviews, and case workflows, empowering organizations to achieve faster, more accurate outcomes in a rapidly evolving industry.
Commence builds transformative health solutions that merge AI with deep clinical context. Through platforms like Amplify, Commence is helping government agencies, providers, and payers move from fragmented systems to fluid intelligence—driving real-world impact through greater data for the greater good.
TechIntelPro empowers B2B technology decision-makers with the latest industry trends, deep insights, leadership perspectives and actionable intelligence to drive both organizational and professional milestones—and thrive on the tech pulse.